Literature DB >> 31166822

Conceptual Model for Accrual to Cancer Clinical Trials.

Simon J Craddock Lee1, Caitlin C Murphy1, Ann M Geiger2, David E Gerber1, John V Cox1, Rasmi Nair1, Celette Sugg Skinner1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31166822      PMCID： PMC6879309          DOI： 10.1200/JCO.19.00101

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  22 in total

1.  Managing accrual in cooperative group clinical trials.

Authors:  Todd L Demmy; Joyce M Yasko; Deborah E Collyar; Mira L Katz; Carol L Krasnov; Margaret J Borwhat; Anne Battershell; Stephen L George
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

2.  Should criteria for inclusion in cancer clinical trials be expanded?

Authors:  David E Gerber; Sandi L Pruitt; Ethan A Halm
Journal:  J Comp Eff Res       Date:  2015-08       Impact factor: 1.744

3.  Provider roles in the recruitment of underrepresented populations to cancer clinical trials.

Authors:  Mollie W Howerton; M Chris Gibbons; Charles R Baffi; Tiffany L Gary; Gabriel Y Lai; Shari Bolen; Jon Tilburt; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass; Jean G Ford
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

4.  American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Authors:  Jeffrey S Weber; Laura A Levit; Peter C Adamson; Suanna Bruinooge; Howard A Burris; Michael A Carducci; Adam P Dicker; Mithat Gönen; Stephen M Keefe; Michael A Postow; Michael A Thompson; David M Waterhouse; Susan L Weiner; Lynn M Schuchter
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

5.  The State of Cancer Care in America, 2017: A Report by the American Society of Clinical Oncology.

Authors: 
Journal:  J Oncol Pract       Date:  2017-03-22       Impact factor: 3.840

6.  National Cancer Institute sponsored cooperative clinical trials.

Authors:  M A Friedman; D F Cain
Journal:  Cancer       Date:  1990-05-15       Impact factor: 6.860

7.  Precision oncology: an overview.

Authors:  Levi A Garraway; Jaap Verweij; Karla V Ballman
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

8.  Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.

Authors:  Sandra Garcia; Ajit Bisen; Jingsheng Yan; Xian-Jin Xie; Suresh Ramalingam; Joan H Schiller; David H Johnson; David E Gerber
Journal:  J Thorac Oncol       Date:  2017-08-09       Impact factor: 15.609

9.  Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations.

Authors:  David E Gerber; Ashley M Lakoduk; Laurin L Priddy; Jingsheng Yan; Xian-Jin Xie
Journal:  Oncologist       Date:  2015-05-27

10.  Consent timing and experience: modifiable factors that may influence interest in clinical research.

Authors:  David E Gerber; Drew W Rasco; Celette Sugg Skinner; Jonathan E Dowell; Jingsheng Yan; Jennifer R Sayne; Yang Xie
Journal:  J Oncol Pract       Date:  2011-12-06       Impact factor: 3.840
View more
  7 in total

1.  Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.

Authors:  Bob T Li; Bobby Daly; Mary Gospodarowicz; Monica M Bertagnolli; Otis W Brawley; Bruce A Chabner; Lola Fashoyin-Aje; R Angelo de Claro; Elizabeth Franklin; Jennifer Mills; Jeff Legos; Karen Kaucic; Mark Li; Lydia The; Tina Hou; Ting-Hui Wu; Bjorn Albrecht; Yi Shao; Justin Finnegan; Jing Qian; Javad Shahidi; Eduard Gasal; Craig Tendler; Geoffrey Kim; James Yan; Phuong Khanh Morrow; Charles S Fuchs; Lianshan Zhang; Robert LaCaze; Stefan Oelrich; Martin J Murphy; Richard Pazdur; Kevin Rudd; Yi-Long Wu
Journal:  Nat Med       Date:  2022-04       Impact factor: 87.241

2.  A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).

Authors:  Laila A Gharzai; Lauren A Szczygiel; Dean A Shumway; Hanna Bandos; Thomas B Julian; Eleftherios P Mamounas; Julia White; Jennifer F De Los Santos; Mark Basik; Patricia A Ganz; Reshma Jagsi
Journal:  Breast Cancer Res Treat       Date:  2021-03-19       Impact factor: 4.872

Review 3.  Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies.

Authors:  Steven M Devine; Mary M Horowitz
Journal:  J Clin Oncol       Date:  2021-01-12       Impact factor: 44.544

4.  Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual.

Authors:  Simon J Craddock Lee; Caitlin C Murphy; David E Gerber; Ann M Geiger; Ethan Halm; Rasmi G Nair; John V Cox; Jasmin A Tiro; Celette S Skinner
Journal:  Med Care       Date:  2021-05-01       Impact factor: 3.178

Review 5.  Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices.

Authors:  Shellie Ellis; Mugur Geana; Tomas Griebling; Charles McWilliams; Jessie Gills; Kelly Stratton; Christine Mackay; Ariel Shifter; Andrew Zganjar; Brantley Thrasher
Journal:  Trials       Date:  2019-10-07       Impact factor: 2.279

Review 6.  Machine learning applications for therapeutic tasks with genomics data.

Authors:  Kexin Huang; Cao Xiao; Lucas M Glass; Cathy W Critchlow; Greg Gibson; Jimeng Sun
Journal:  Patterns (N Y)       Date:  2021-08-09

7.  Role of Oncology Advanced Practitioners to Enhance Clinical Research.

Authors:  Christa Braun-Inglis; Leigh M Boehmer; Laura J Zitella; Brianna Hoffner; Yurii B Shvetsov; Jeffrey L Berenberg; Randall A Oyer; Al B Benson
Journal:  J Adv Pract Oncol       Date:  2022-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.